Marshall Wace’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,747
Closed -$123K 4037
2022
Q2
$123K Sell
11,747
-370,760
-97% -$2.76M ﹤0.01% 3250
2022
Q1
$3.38M Buy
382,507
+187,055
+96% +$1.42M 0.01% 1708
2021
Q4
$1.35M Buy
195,452
+183,405
+1,522% +$2.69M ﹤0.01% 2303
2021
Q3
$150K Buy
+12,047
New +$174K ﹤0.01% 2844
2021
Q2
Sell
-25,569
Closed -$534K 3393
2021
Q1
$534K Buy
+25,569
New +$539K ﹤0.01% 1912
2020
Q4
Sell
-105,641
Closed -$1.2M 2311
2020
Q3
$1.2M Sell
105,641
-231,693
-69% -$2.86M 0.01% 964
2020
Q2
$4.6M Buy
337,334
+77,543
+30% +$1.07M 0.03% 495
2020
Q1
$3.38M Buy
259,791
+244,321
+1,579% +$4.36M 0.03% 478
2019
Q4
$312K Buy
+15,470
New +$376K ﹤0.01% 1267
2019
Q2
Sell
-18,582
Closed -$371K 1995
2019
Q1
$371K Buy
+18,582
New +$339K ﹤0.01% 1218
2018
Q4
Sell
-142,836
Closed -$2.54M 1884
2018
Q3
$2.54M Buy
+142,836
New +$3.23M 0.02% 613
2017
Q1
Sell
-156,432
Closed -$5.95M 838
2016
Q4
$5.95M Buy
+156,432
New +$7.44M 0.04% 430
2015
Q2
Sell
-52,233
Closed -$2.15M 1089
2015
Q1
$2.15M Buy
+52,233
New +$2.35M 0.03% 456

Other funds holding RDUS

Marshall Wace's RDUS Position: Q3 2022 in Review

Marshall Wace sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 11,747 shares — an estimated $123K sold.

Marshall Wace first reported a position in RDUS in Q1 2015 and held it in 13 quarters. The position peaked at $5.95M in Q4 2016. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.

  • Marshall Wace reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
  • Marshall Wace sold 11,747 Radius Health, Inc. shares in Q3 2022, an estimated $123K.
  • Marshall Wace first reported a position in Radius Health, Inc. in Q1 2015 and held it in 13 quarters.
  • Marshall Wace's Radius Health, Inc. position peaked at $5.95M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.